| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |